MannKind Stock Tumbled Thursday: What Investors Should Know
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
72 articles
Personalis (PSNL) 2025 Earnings: Outlook and Insights
As investors prepare for Personalis (PSNL) 2025 earnings, this guide breaks down what to watch, how to interpret the ...
Vericel (VCEL) 2025 Earnings: A Practical Investor Guide
A practical, investor-focused guide to vericel (vcel) 2025 earnings. Learn how revenue, margins, and milestones could...
Delcath (DCTH) 2025 Earnings Outlook for Investors
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
MiMedx (MDXG) 2025 Earnings: Key Takeaways and Outlook
MiMedx (MDXG) 2025 earnings scrutiny goes beyond one quarter. This guide breaks down what to watch in the Q4 call, ho...
Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Axogen (AXGN) 2025 Earnings: Key Takeaways for Investors
As Axogen prepares to report its Q4 2025 results, investors want clarity on growth, margins, and guidance. This artic...
Repligen (RGEN) 2025 Earnings: Outlook & Takeaways
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Here's Grail Stock Slumped: What Investors Should Know Now
Grail stock faced another sharp move as trial news weighed on sentiment. This guide unpacks why the slump happened, w...
Why Viking Therapeutics Stock More Is Turning Heads Today
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
This Fund Nearly Million Bet on GRAIL: Lessons for Investors
A leading hedge fund poured nearly $40 million into GRAIL last quarter, only to see the stock tumble. This article un...
Kodiak Sciences Stock 480% Rally: Big Fund Buy Explained
A prominent hedge fund unveiled a sizable Kodiak Sciences stake, triggering chatter about what the kodiak sciences st...
Related Topics
#Investing (55)
#Stock Analysis (16)
#Earnings Analysis (16)
#Stock Market News (11)
#Earnings (8)
#Stock Market (7)
#Portfolio Management (7)
#Insider Trading (7)
#Portfolio Strategy (6)
#risk-management (5)
#Hedge Funds (5)
#Investing Strategies (3)
#Investing Strategy (3)
#CRISPR (3)
#Viking Therapeutics (3)